Woodline Partners LP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1784547
San Francisco, CA
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,316,997
+$3,765,461 QoQ
Shares Held
200,184
0.0% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#72
of 497 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ARWR ranks #70 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ARWR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,316,997 | 200,184 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,551,536 | 200,184 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,568,215 | 400,184 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,495,449 | 1,000,158 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,789,264 | 746,156 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,162,109 | 562,175 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,795,271 | 840,174 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,770,429 | 865,794 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,351,252 | 821,518 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,890,960 | 555,628 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $28,371,922 | 927,187 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,588,514 | 468,497 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,422,183 | 95,967 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,042,845 | 592,238 | Shares | Sole | 2023-05-15 | |
| 2020-09-30 | $3,761,936 | 87,365 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||